TP53TG1 Knockout A-549 Cell Line

The choice depends on whether you are studying TP53TG1's role as a p53-induced long non-coding RNA or its tumor-suppressive functions in cancer. The Knockout line is appropriate for asking whether TP53TG1 lncRNA is required for downstream p53 response programs — particularly relevant in A-549, which has TP53 wild-type status (relatively rare among lung cancer lines). Overexpression is useful for testing whether elevated TP53TG1 is sufficient to recapitulate p53-induced phenotypes. For p53 pathway research, the EDITGENE TP53TG1 Knockout in A-549 is particularly informative because A-549's intact p53 status allows the contribution of TP53TG1 to be assessed in a p53-competent background — many lung cancer lines have p53 mutations that complicate this analysis. Rescue experiments for lncRNAs require careful design — typically using stable lncRNA expression from controlled promoters.

Primary applications: • p53 response analysis: comparison of p53 target gene induction following nutlin-3a or genotoxic stress treatment between wild-type and TP53TG1-knockout A-549 cells. • YBX1 sequestration assays: TP53TG1 has been reported to bind and sequester YBX1; analyses of YBX1 nuclear/cytoplasmic distribution and oncogenic target gene expression in the knockout. • Cancer phenotype assays: proliferation, apoptosis sensitivity, and chemoresistance in lung cancer-relevant contexts. • lncRNA mechanism studies: RNA-protein interaction mapping (RNA pull-down, RIP-seq) to expand understanding of TP53TG1 functional interactions. EDITGENE recommends this model for researchers investigating p53-induced long non-coding RNAs, tumor suppressor lncRNA biology, and lung cancer-relevant non-coding gene regulation.

Yes, with important considerations specific to lncRNA rescue: • Construct design: TP53TG1 is a long non-coding RNA — rescue requires careful preservation of the full RNA structure rather than coding sequence considerations. Use the validated TP53TG1 transcript sequence with no tag-related modifications. • Expression strategy: stable expression from RNA polymerase II promoters (CMV, EF1α) with optimized 5' caps and poly(A) signals is preferred over polymerase III systems for full-length lncRNA rescue. • Functional domain rescue: where TP53TG1 functional domains have been mapped (e.g., YBX1-binding regions), truncation or deletion constructs can distinguish functional regions. • Functional readout: rescue should restore YBX1 sequestration (subcellular fractionation) and YBX1 target gene regulation, in addition to p53 response amplification. A-549 supports stable lncRNA expression with standard lentiviral systems; copy number titration may be necessary to approximate endogenous TP53TG1 levels.